Tolerability in Glaucoma Patients Switched from Preserved to Preservative-Free Prostaglandin-Timolol Combination: A Prospective Real-Life Study.

Sonja Jandroković Sania Vidas Pauk Dina Lešin Gaćina Ivan Skegro Martina Tomić Sanja Masnec Tomislav Kuzman Miro Kalauz

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

A switch from preserved PG-timolol FCs to PF-LT improved tolerability and optimized IOP control, providing better adherence with greater chances of treatment success.

Keyphrases

end stage renal disease
open label
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
randomized controlled trial
metabolic syndrome
adipose tissue
double blind
placebo controlled
glycemic control